Adam Coape-Arnold: Biotechnology Meets Psychedelics | Episode 198

Adam B. Coape-Arnold is the CEO and Founder of Cubed Biotech Inc. He has a decade of experience owning and operating premium brands in the regulated industries of raw dairy, yogurt, and cannabis, with over $50 million in sales to date. 

Cubed is a Montreal-based Canadian company that intends to develop & produce psychedelic medicine inspired by historical ethnobotany to disrupt the current treatments of mental illness & addiction. Cubed intends to cultivate, extract and also synthesize natural entheogens (Psilocybin from Mushrooms, Mescaline from Cacti, and Ayahuasca’s DMT & MAO-inhibitors), manufacture pharmaceutical mental-health & addiction medicines and develop its own proprietary compounds through clinical trials for pharmaceutical-grade distribution and commercialization.

https://cubed3biotech.com